Emergent BioSolutions Inc. (EBS)

NYQ – Real Time Price. Currency in USD

4.45

+0.01 (0.11%)

Market open: Aug 12, 2026, 10:50 AM EDT

4.46

+0.01 (0.22%)

Previous after-hours: Aug 11, 2026, 7:57 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

743M

1.04B

1.05B

1.12B

Cost of goods sold

-392M

-738M

-757M

-750M

Gross Profit

351M

305M

293M

367M

Operating expenses (excl. COGS)

-240M

-364M

-465M

-526M

Operating Income

110M

-58M

-172M

-159M

Non-operating income, total

-27M

-85M

-559M

-60M

Pretax income

83M

-143M

-731M

-219M

Equity in earnings

Taxes

-30M

-48M

-29M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

53M

-191M

-761M

-212M

Discontinued operations

Net income

53M

-191M

-761M

-212M

Dilution adjustment

Preferred dividends

Emergent BioSolutions Inc. (EBS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Emergent BioSolutions Inc. (EBS)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Emergent BioSolutions Inc. (EBS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Emergent BioSolutions Inc. (EBS)

Income Statement (Annual)

Income Statement (Annual)